Cargando…
The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
The calcium-activated potassium channel KCa3.1 controls different cellular processes such as proliferation and volume homeostasis. We investigated the role of KCa3.1 in experimental and human liver fibrosis. KCa3.1 gene expression was investigated in healthy and injured human and rodent liver. Effec...
Autores principales: | Sevelsted Møller, Linda, Fialla, Annette Dam, Schierwagen, Robert, Biagini, Matteo, Liedtke, Christian, Laleman, Wim, Klein, Sabine, Reul, Winfried, Koch Hansen, Lars, Rabjerg, Maj, Singh, Vikrant, Surra, Joaquin, Osada, Jesus, Reinehr, Roland, de Muckadell, Ove B. Schaffalitzky, Köhler, Ralf, Trebicka, Jonel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926059/ https://www.ncbi.nlm.nih.gov/pubmed/27354175 http://dx.doi.org/10.1038/srep28770 |
Ejemplares similares
-
Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
por: Lambertsen, Kate Lykke, et al.
Publicado: (2012) -
High Expression of KCa3.1 in Patients with Clear Cell Renal Carcinoma Predicts High Metastatic Risk and Poor Survival
por: Rabjerg, Maj, et al.
Publicado: (2015) -
Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis
por: Lozano-Gerona, Javier, et al.
Publicado: (2020) -
Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion
por: Fialla, A. D., et al.
Publicado: (2018) -
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)